We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look ...

The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024. The Nasdaq Composite ...

UnitedHealth Group has received a consensus “Buy” rating from 21 brokerages, with 19 issuing a buy and two giving a strong ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

In the latest trading session, UnitedHealth Group (UNH) closed at $486.04, marking a +1.21% move from the previous day. This move outpaced the S&P 500's daily loss of 0.76%. Meanwhile, the Dow ...

Representative Jefferson Shreve (R-Indiana) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 09th, the Representative disclosed that they had sold ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

T he U.S. stock market experienced a sharp decline on Friday as investors grew increasingly concerned about inflation and the potential impact of tariffs on the economy. The Dow J ...

Vertex Pharmaceuticals (NASDAQ:VRTX) ended a four-day winning streak on Thursday after UnitedHealth (NYSE:UNH) placed its new ...

Investing.com -- Vertex Pharmaceuticals Inc (NASDAQ: VRTX ).’s newly approved non-opioid pain medication, Journavx, has been included in UnitedHealth Group Inc (NYSE: UNH ).’s coverage, according to ...